Three Takeaways for the Future of GI 1. Cancer Screening Enters a New Scale PhaseAbbott’s acquisition signals a structural shift: early cancer detection (MCED, MRD, noninvasive screening) is moving from emerging innovation to mass-market scale.With Abbott’s global distribution, regulatory experience, and manufacturing capacity, adoption will accelerate far beyond what Exact could have achieved independently. 2. Cologuard Just Got a Global Engine Behind It Expect a dramatic expansion of both Cologuard and Cologuard Plus—driven by: For GI practices, this means a larger population entering screening earlier, often before they reach specialist care—reshaping referral patterns and CRC prevention strategies. 3. Abbott Is…
Author: Abhay Panchal
In a major move to strengthen the link between digestive and mental health, Cylinder Health — formerly Vivante Health — has appointed Dr. Grace Niu as Head of Gut-Brain Health and Dr. Ujjwal Ramtekkar to its Clinical Advisory Board. Both experts bring deep clinical and academic experience in neuroscience and behavioral medicine, signaling a strategic push toward integrated gut-brain care. With over 70 million Americans affected by GI disorders, Cylinder’s virtual platform already supports patients with conditions like IBS, chronic pain, anxiety, and disordered eating. The new appointments will expand gut-brain–specific therapy, clinical triage, and digital psychological care across all…
After years of consolidation and corporate medicine, a quiet rebellion is taking root — doctors are reclaiming control of their practices. In her article for Medical Economics, Melissa Starowitz explores why growing numbers of physicians are leaving large health systems to build independent models centered on autonomy, purpose, and patient connection. With burnout rates nearing 63% and administrative tasks consuming twice as much time as patient care, many clinicians feel trapped in bureaucracy. Independence, once viewed as risky, is now seen as a path to renewal — offering freedom to craft care models aligned with personal values, choose technologies, and…
In a candid interview with GI and Hepatology News, Dr. Manol Jovani, medical director for advanced therapeutic endoscopy at Gastro Health Florida, shares lessons from a career spanning 70+ research papers, global presentations, and groundbreaking work in third-space and bariatric endoscopy. Dr. Jovani recounts performing a 12-hour endoscopic removal of early gastric cancer, preserving a patient’s stomach and quality of life—a feat once possible only through surgery. He reflects on how lumen-apposing stents and third-space endoscopy are redefining minimally invasive care, enabling drainage procedures and early cancer treatment without open operations.
In a major announcement from Tokyo, Olympus Corporation revealed a bold new strategy to transform the future of endoscopy-enabled care—shifting from traditional hardware to AI-powered, robotic, and cloud-connected solutions that promise earlier detection, safer procedures, and seamless continuity of care. Under CEO Bob White’s leadership, Olympus’ three strategic pillars—Innovation-driven Growth, Simplicity, and Accountability—aim to accelerate MedTech innovation while improving operational agility. The company will undergo a global organizational transformation projected to yield ¥24 billion in annual savings and streamline its workforce by about 2,000 positions. Financially, Olympus is targeting 5% annual revenue growth, 10% EPS CAGR, and enhanced free cash…
Private equity’s investments in healthcare have often struggled to meet expectations. Top-line growth and attractive exit multiples are elusive in a sector weighed down by legacy systems, labor costs, and regulatory complexity. The urgent question facing investors, operating partners, and portfolio company leaders is: How can we reinvigorate returns and unlock enterprise value? The article explores how AI is already making an impact in specific use cases in HealthTech and tech-enabled services.
The highest-paid gastroenterologist in New York City earns $980,900 per year, according to Medscape’s salary reporter tool. Here is what the five highest-paid gastroenterologists in New York City earn each year, their amount of experience and their practice setting.
Healio Gastroenterology and its collaborators unveiled the newest class of Disruptive Innovators Award recipients during the ACG Annual Meeting in Phoenix. Each honoree across nine categories embodies the heart of gastroenterology or hepatology, driving innovation and progress within the field. Readers — helped select these trailblazers, casting more than 3,500 votes to recognize those making the most significant impact among an outstanding lineup of physicians, researchers, influencers, organizations and industry leaders.
The booming market for at-home microbiome kits promises insights into digestion, disease risk, and even longevity—but leading gastroenterologists warn that the science hasn’t caught up with the marketing. Experts like Dr. Eamonn Quigley of Houston Methodist note that while gut bacteria clearly influence health, the field is still in its infancy: most of the variability between people remains unexplained. These tests—often costing $300–$500—aren’t FDA-regulated and provide reports comparing users’ microbes to a supposed “ideal,” leading to confusion and frustration for physicians and patients alike. Compounding concerns, many testing companies also sell supplements or probiotics tied to their results, creating conflicts…
Digital chronic-care leader Omada Health is set to begin prescribing GLP-1 weight-loss drugs nationwide in 2026, marking a major expansion of its obesity-care platform. The move follows White House deals with Eli Lilly and Novo Nordisk to lower drug prices, signaling broader public access. Omada’s GLP-1 program—already supporting over 100,000 members—combines prescribing with AI-driven coaching, nutrition guidance, and remote monitoring. New data show that 63% of members maintained or continued losing weight a year after stopping GLP-1s when paired with Omada’s behavior-change model.